Arvida Labs is a leading manufacturer of rare cannabinoids. They are able to create phytocannabinoids via chemistry vs chromatography at scale. Using their patent-pending processes they have shown the ability to modify the chemical structure of CBD & CBG into the following rare cannabinoids: D8, D9, D10, THCv, THC-O-Acetate, Hexahydroxycannabinol, CBND, CBC, CBN. 

Some of these cannabinoids are naturally occurring in small quantities that make it nearly impossible to scale via traditional extraction, distillation, and refinement. Arvida Labs has filed for multiple patents on their methods of producing these rare cannabinoids at scale, without the production of unknown isomers, at the highest purity. They are working with leading analytical labs to develop standards for some of these cannabinoids that otherwise do not have existing testing standards.